BAT introduces new vape products "VuseS Go" in Korea.

Aug.27.2024

British American Tobacco (BAT) Korea launches two new vape products "VuseS Go" in South Korea, aiming to expand market share.

According to a report on n.news on August 27th, British American Tobacco (BAT) Korea has announced the launch of two new vape products in South Korea, named "VuseS Go” in flavors of “Tropical Blend” and “Ruby Spark.”

According to reports, the new product uses a closed system and contains natural nicotine. The e-liquid capacity is 2.0 milliliters with a nicotine content of 0.9%. It is priced at 10,000 Korean won, approximately $7.5.

With the launch of this new product, BAT Rosmans has expanded the "ViewS Go" product series to a total of 10 models.

A spokesperson for British American Tobacco Korea has stated that the company will continue to focus on developing products that meet customer demands and trends, in order to provide better alternatives for adult smokers.

According to reports, since its launch in the South Korean market last July, the brand has accumulated sales of over 1 million units in just six months, successfully establishing itself as a leading brand in the vape market.

References:

[1] BAT, 트로피컬 담은 ‘뷰즈 고' 신제품 2종 출시

Also Read:

[1] Survey Report: Smoking Rates Among South Korean Adults 2019-2023

[2] PMI Korea Introduces New Marlboro Vista Series 'Garden Splash'

[3] South Korea's Tobacco Export to Russia Reaches Record High

[4] Supporting Amendment to Classify Synthetic Nicotine as Tobacco: Asia Time

[5] PMI Korea Seizes Market Share with Updated E-cigarette Products

[6] KT&G and PMI Collaborate to Launch New HNB E-Cigarette in US

[7] Rising Trend of Teenage E-cigarette Use in South Korea

[8] Korean Health Survey Reveals Increase in Youth E-cigarette Use

#vuse #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry

Heno Biotech was invited to deliver a keynote address at PouchEX Stockholm 2025, presenting a new supply chain competency model for the nicotine pouch sector. The company showcased its end-to-end capabilities—from scientific research and advanced manufacturing to global regulatory compliance—underscoring the critical role of supply chain upgrading in driving sustainable industry growth.

Nov.24

U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned

Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.

Nov.06 by 2FIRSTS.ai

The U.S. Department of Justice and FDA seized 2.1 million e-cigarettes and 12 distributors and retailers were sued

Recently, the U.S. Department of Justice and the FDA announced a joint crackdown on illegal e-cigarettes, seizing over 2.1 million unauthorized e-cigarette products from five distributors and six retailers in seven states. The companies involved had previously received warnings from the FDA but continued to sell products without market approval. This operation was jointly carried out by multiple government departments, and civil injunction lawsuits have been filed against 12 related companies an

Sep.30 by 2FIRSTS.ai

Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade

California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.